Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Autolus Therapeutics (AUTL) Other Non Operating Income (2017 - 2025)

Historic Other Non Operating Income for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to -$911000.0.

  • Autolus Therapeutics' Other Non Operating Income rose 9234.45% to -$911000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year increase of 24779.25%. This contributed to the annual value of -$1.0 million for FY2024, which is 13789.31% down from last year.
  • As of Q3 2025, Autolus Therapeutics' Other Non Operating Income stood at -$911000.0, which was up 9234.45% from $1.5 million recorded in Q2 2025.
  • Autolus Therapeutics' 5-year Other Non Operating Income high stood at $951.0 million for Q3 2021, and its period low was -$11.9 million during Q3 2024.
  • In the last 5 years, Autolus Therapeutics' Other Non Operating Income had a median value of $782000.0 in 2023 and averaged $50.3 million.
  • In the last 5 years, Autolus Therapeutics' Other Non Operating Income surged by 3800354.72% in 2021 and then tumbled by 58667.05% in 2024.
  • Over the past 5 years, Autolus Therapeutics' Other Non Operating Income (Quarter) stood at -$86000.0 in 2021, then soared by 7369.77% to $6.3 million in 2022, then crashed by 50.72% to $3.1 million in 2023, then surged by 270.01% to $11.4 million in 2024, then plummeted by 107.99% to -$911000.0 in 2025.
  • Its Other Non Operating Income stands at -$911000.0 for Q3 2025, versus $1.5 million for Q2 2025 and $1.2 million for Q1 2025.